Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

OHSU partners with UO, Harvard to expedite research into compounds that may prevent Fanconi anemia

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Restanza shows greater efficacy against species of Plasmodium that cause malaria

Restanza shows greater efficacy against species of Plasmodium that cause malaria

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

Lyophilized heparin demonstrates better ability to preserve cord blood stem cells than CPD: Study

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Researchers study how hematopoietic cells react when Epo levels increase

Researchers study how hematopoietic cells react when Epo levels increase

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

OnePath Gaucher Application available for patients with Type 1 Gaucher disease

NormOxys raises $17.5M in Series B financing round

NormOxys raises $17.5M in Series B financing round

Sangamo's ZFP Therapeutics technology highlighted at ASGCT Annual Meeting

Sangamo's ZFP Therapeutics technology highlighted at ASGCT Annual Meeting

Phase 1 clinical trial of OXY111A initiated

Phase 1 clinical trial of OXY111A initiated

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Phase II study results of Lilly Oncology's tasisulam for metastatic melanoma to be presented at 46th ASCO

Phase II study results of Lilly Oncology's tasisulam for metastatic melanoma to be presented at 46th ASCO

Chronic kidney disease patients with depression have poorer health outcomes: Researchers

Chronic kidney disease patients with depression have poorer health outcomes: Researchers

New book offers practical knowledge on celiac disease, gluten-related disorders

New book offers practical knowledge on celiac disease, gluten-related disorders

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

FibroGen's FG-3019 human monoclonal antibody against CTGF reverses progression of lung fibrosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.